|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Burden of disease in older adults
Keynote Lecture by Stefan Gravenstein, Brown University
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Burden of disease in infants
Keynote Lecture by Simon Drysdale, St George's University Hospitals NHS Foundation Trust
Diabetes Community Pledge for the European Parliament Elections 2024
Sign the Diabetes Community Pledge to support the 32 million people living with diabetes in the European Union and their families. Take action by creating a strong EU diabetes policy framework supportive of national diabetes action plans.
First results in using new tools to tackle respiratory syncytial virus
Protecting infants from RSV with new tools: vaccines for pregnant women and use of monoclonal antibodies have been approved for use in the European Union to prevent RSV among young children. Are those tools working?
News
Policy & Recommendations
Flash Report: Third meeting of the Public Health Expert Group (PHEG)
Chaired by DG SANTE, EU Member States agreed on prioritising for 2024-2026: health promotion & prevention of non-communicable diseases; healthy longevity/lifelong prevention; vaccine-preventable diseases & vaccination; and long COVID, amongst others.
News
Policy & Recommendations
COP28: climate crisis is a health crisis, say scientific and health-focused organisations and experts
ESWI endorses a joint statement initiated by ERS and ELF to prioritise action to mitigate but also adapt to the health effects of climate change, to prepare societies and communities for a much more complex future.
PROGRAMMING survey on educational needs in the care of older people
The COST Action Promoting geriatric medicine in countries where it is still emerging (PROGRAMMING) has launched a survey aiming to map the educational interests and needs of current and future healthcare professionals in the field of care for older people
RSV IMMUNISATION FOR INFANTS IN EUROPE: ARE OUR HEALTH SYSTEMS READY?
EHMA publishes a paper based on expert insight from across Europe, exploring the challenges and opportunities of implementing RSV immunisation programmes in different country contexts.
|
9th Influenza Conference 2023
The Influenza B/Yamagata lineage appears to become extinct: implications for quadrivalent influenza vaccines?
SPI08 session from #ESWI2023
